Which of the following medications are contraindicated in a patient with coronary artery disease (CAD) who has undergone recent angioplasty: prednisone, pregabalin, and Myonal (nimesulide/eperisone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

None of these medications are absolutely contraindicated in CAD patients post-angioplasty

Among the three medications listed, none carry absolute contraindications for patients with coronary artery disease (CAD) who have undergone angioplasty, though prednisone requires the most caution due to cardiovascular risks.

Medication-Specific Analysis

Pregabalin - Safe to Use

  • No cardiovascular contraindications exist in the FDA labeling 1
  • The drug label lists only "previous intracranial hemorrhage or ongoing bleeds" as contraindications - no mention of CAD or post-PCI status 1
  • Common adverse effects include dizziness, somnolence, peripheral edema, and weight gain, but these do not contraindicate use in CAD patients 1
  • The peripheral edema (occurring in 9-12% at higher doses) is not a cardiovascular contraindication but may require monitoring 1

Prednisone - Use with Caution

  • Not contraindicated, but carries cardiovascular risks that warrant careful consideration
  • Corticosteroids can cause dyslipidemia, hypertension, and theoretically increase cardiovascular risk with prolonged high-dose use 2
  • Notably, corticosteroids increase the risk of left ventricular free wall rupture when used in the immediate post-myocardial infarction period by delaying myocardial scar formation 2
  • Key timing consideration: If the angioplasty was performed for acute MI, avoid corticosteroids in the immediate post-infarction period
  • For chronic CAD or remote angioplasty, use the lowest effective dose for the shortest duration while monitoring blood pressure and lipids 2

Myonal (Eperisone) - Likely Safe

  • This is a muscle relaxant with no established cardiovascular contraindications
  • No evidence in the provided literature suggests contraindication in CAD patients
  • The concern with NSAIDs in CAD is well-documented 3, but eperisone is not an NSAID

Clinical Approach

If the angioplasty was for acute MI:

  • Avoid prednisone during the acute healing phase (first several weeks)
  • Pregabalin and Myonal can be used safely

If the angioplasty was elective or remote:

  • All three medications can be used
  • For prednisone: minimize dose and duration, monitor cardiovascular risk factors
  • Ensure the patient is on guideline-directed medical therapy (aspirin or P2Y12 inhibitor, statin, beta-blocker if indicated) 4, 5

Important Caveat

The primary focus post-angioplasty should be on mandatory antithrombotic therapy - either dual antiplatelet therapy (DAPT) for up to 6 months or appropriate single antiplatelet therapy thereafter 4. None of the three medications in question interfere with this critical therapy.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.